Skip to main content

Table 1 Summary of clinical findings

From: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation

Case

Case one (G51D)

Case two (G51D)

Case three (G51D)

H50Q

Duplication

Age of onset (years)

19

69

46

71

38

Disease duration (years)

29

6

6

12

12

Presenting symptoms

Resting hand tremor, anxiety

Resting hand tremor, anxiety and depression

Resting hand tremor, depression

Resting hand tremor

Resting hand tremor and tongue tremor

Final clinical diagnosis

Familial pallidopyramidal syndrome

Parkinson’s disease with dementia

Parkinson’s disease with dementia

Parkinson’s disease

FTDP-17

Levodopa responsive

Good and sustained

Transient

Transient

Good and sustained

Transient

Motor fluctuation

Yes

No

No

No

No

Dystonia

Wearing-off foot dystonia

Blepharospasm (unrelated to dopamine replacement therapy)

No

Blepharospasm (unrelated to dopamine replacement therapy)

Blepharospasm and cervical dystonia (unrelated to dopamine replacement therapy)

Latency from first symptom of onset of cognitive impairment (years)

8

2

2

Not applicable

9

Prominent cognitive impairment

Yes

Yes

Yes

No

Yes

Predominant frontal cognitive impairment

No

Yes (emotional lability, apathy, disinhibition)

Yes (perseveration, frontal executive impairment, grasp reflex)

No

Yes (obsessive behaviour, self-neglect, markedly increased appetite, grasp reflex, perseveration, motor recklessness)

Visual hallucinations (unrelated to drug effect)

Yes

Yes

Yes

No

Yes

Autonomic dysfunction

Yes

Yes

Yes

No

Yes

Pyramidal signs (pathological reflexes and extensor plantar response)

Yes

Yes

Yes

No

Yes

Additional features

Myoclonus seizures

Vertical supranuclear gaze palsy, apraxia of eyelid opening

Not applicable

No

Not applicable

Family history of parkinsonism

Father, sister

Mother, Aunt, brother, Son

Mother, uncle, grandmother, great aunt

No

Father, male cousin, grandmother, two great aunts